Newly Diagnosed Glioblastoma With Radiotherapy Therapeutics
1. Temodar patent expiration
Treatment: Treatment of malignant neoplasm
TEMODAR's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5260291 (Pediatric) | MERCK SHARP DOHME | Tetrazine derivatives |
Feb, 2014
(11 years ago) | |
| US8623868 | MERCK SHARP DOHME | Processes of making and using pharmaceutical formulations of antineoplastic agents |
Feb, 2023
(2 years ago) | |
| US6987108 | MERCK SHARP DOHME | Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
Sep, 2023
(2 years ago) | |
| US7786118 | MERCK SHARP DOHME | Pharmaceutical formulations of antineoplastic agents |
Feb, 2023
(2 years ago) | |
| US5260291 | MERCK SHARP DOHME | Tetrazine derivatives |
Aug, 2013
(12 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Mar 15, 2012 |
Drugs and Companies using TEMOZOLOMIDE ingredient
Market Authorisation Date: 11 August, 1999
Dosage: CAPSULE; POWDER
How can I launch a generic of TEMODAR before it's drug patent expiration?
More Information on Dosage
TEMODAR family patents
